Related references
Note: Only part of the references are listed.Identification and Validation of the Immune Regulator CXCR4 as a Novel Promising Target for Gastric Cancer
Shuai Xue et al.
FRONTIERS IN IMMUNOLOGY (2021)
Identification and validation of stromal-tumor microenvironment-based subtypes tightly associated with PD-1/PD-L1 immunotherapy and outcomes in patients with gastric cancer
Qianqian Ren et al.
CANCER CELL INTERNATIONAL (2020)
Exploring TCGA database for identification of potential prognostic genes in stomach adenocarcinoma
Lin Zhou et al.
CANCER CELL INTERNATIONAL (2020)
Blocking CXCR4 alleviates desmoplasia, increases T-lymphocyte infiltration, and improves immunotherapy in metastatic breast cancer
Ivy X. Chen et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2019)
CXCR4 as a prognostic biomarker in gastrointestinal cancer: a meta-analysis
Qingtao Jiang et al.
BIOMARKERS (2019)
Identification and validation of an immune cell infiltrating score predicting survival in patients with lung adenocarcinoma
Xiaodong Yang et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2019)
Pan-Asian adapted ESMO Clinical Practice Guidelines for the management of patients with metastatic gastric cancer: a JSMO-ESMO initiative endorsed by CSCO, KSMO, MOS, SSO and TOS
K. Muro et al.
ANNALS OF ONCOLOGY (2019)
Tumor microenvironment: Interactions and therapy
Masoud Najafi et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2019)
Role of the tumor microenvironment in PD-L1/PD-1-mediated tumor immune escape
Xianjie Jiang et al.
MOLECULAR CANCER (2019)
CXCR4 overexpression is correlated with poor prognosis in colorectal cancer
Chao Xu et al.
LIFE SCIENCES (2018)
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Freddie Bray et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2018)
Dendritic Cells and CD8 T Cell Immunity in Tumor Microenvironment
Chunmei Fu et al.
FRONTIERS IN IMMUNOLOGY (2018)
CXCR4 inhibitors could benefit to HER2 but not to triple-negative breast cancer patients
S. Lefort et al.
ONCOGENE (2017)
Prognostic and predictive value of circulating tumor cells and CXCR4 expression as biomarkers for a CXCR4 peptide antagonist in combination with carboplatin-etoposide in small cell lung cancer: exploratory analysis of a phase II study
Ravi Salgia et al.
INVESTIGATIONAL NEW DRUGS (2017)
Imatinib and Nilotinib Off-Target Effects on Human NK Cells, Monocytes, and M2 Macrophages
Francesca Bellora et al.
JOURNAL OF IMMUNOLOGY (2017)
A positive crosstalk between CXCR4 and CXCR2 promotes gastric cancer metastasis
Z. Xiang et al.
ONCOGENE (2017)
CXCR4-expressing Mist1+ progenitors in the gastric antrum contribute to gastric cancer development
Kosuke Sakitani et al.
ONCOTARGET (2017)
Development and Validation of an Individualized Immune Prognostic Signature in Early-Stage Nonsquamous Non-Small Cell Lung Cancer
Bailiang Li et al.
JAMA ONCOLOGY (2017)
KEGG as a reference resource for gene and protein annotation
Minoru Kanehisa et al.
NUCLEIC ACIDS RESEARCH (2016)
Chemotherapy-Induced IL34 Enhances Immunosuppression by Tumor-Associated Macrophages and Mediates Survival of Chemoresistant Lung Cancer Cells
Muhammad Baghdadi et al.
CANCER RESEARCH (2016)
Macrophages and Therapeutic Resistance in Cancer
Brian Ruffell et al.
CANCER CELL (2015)
Engineering NK Cells Modified With an EGFRvIII-specific Chimeric Antigen Receptor to Overexpress CXCR4 Improves Immunotherapy of CXCL12/SDF-1α-secreting Glioblastoma
Nadja Müller et al.
JOURNAL OF IMMUNOTHERAPY (2015)
The prognostic landscape of genes and infiltrating immune cells across human cancers
Andrew J. Gentles et al.
NATURE MEDICINE (2015)
Expression of CXCR4 and breast cancer prognosis: a systematic review and meta-analysis
Zhigang Zhang et al.
BMC CANCER (2014)
Prognostic B-cell Signatures Using mRNA-Seq in Patients with Subtype-Specific Breast and Ovarian Cancer
Michael D. Iglesia et al.
CLINICAL CANCER RESEARCH (2014)
Prognostic implications of tumor-infiltrating FoxP3+regulatory T cells and CD8+cytotoxic T cells in microsatellite-unstable gastric cancers
Kyung-Ju Kim et al.
HUMAN PATHOLOGY (2014)
CXCL12/CXCR4 Blockade by Oncolytic Virotherapy Inhibits Ovarian Cancer Growth by Decreasing Immunosuppression and Targeting Cancer-Initiating Cells
Margaret Gil et al.
JOURNAL OF IMMUNOLOGY (2014)
CXCR4, but not CXCR7, Discriminates Metastatic Behavior in Non-Small Cell Lung Cancer Cells
Young H. Choi et al.
MOLECULAR CANCER RESEARCH (2014)
Targeting CXCL12 from FAP-expressing carcinomaassociated fibroblasts synergizes with anti-PD-L1 immunotherapy in pancreatic cancer
Christine Feig et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
B cell-regulated immune responses in tumor models and cancer patients
Carlo Fremd et al.
ONCOIMMUNOLOGY (2013)
Tumour micro-environment elicits innate resistance to RAF inhibitors through HGF secretion
Ravid Straussman et al.
NATURE (2012)
Safety and Activity of Anti-PD-L1 Antibody in Patients with Advanced Cancer
Julie R. Brahmer et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
CXCL12-CXCR4 chemokine signaling is essential for NK-cell development in adult mice
Mamiko Noda et al.
BLOOD (2011)
Hallmarks of Cancer: The Next Generation
Douglas Hanahan et al.
CELL (2011)
CD20+ B Cells: The Other Tumor-Infiltrating Lymphocytes
Brad H. Nelson
JOURNAL OF IMMUNOLOGY (2010)
The humoral immune system has a key prognostic impact in node-negative breast cancer
Marcus Schmidt et al.
CANCER RESEARCH (2008)
How to build and interpret a nomogram for cancer prognosis
Alexia Iasonos et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Inhibition of CXCR4 activity with AMD3100 decreases invasion of human colorectal cancer cells in vitro
Ji-Kun Li et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2008)
Maintenance of the hematopoietic stem cell pool by CXCL12-CXCR4 chemokine signaling in bone marrow stromal cell niches
Tatsuki Sugiyama et al.
IMMUNITY (2006)
Expression of CXCR4 predicts poor prognosis in patients with malignant melanoma
S Scala et al.
CLINICAL CANCER RESEARCH (2005)
Expression of CXCR4 and CXCL12 (SDF-1) in human prostate cancers (PCa) in vivo
YX Sun et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2003)
Involvement of chemokine receptors in breast cancer metastasis
A Müller et al.
NATURE (2001)
Time-dependent ROC curves for censored survival data and a diagnostic marker
PJ Heagerty et al.
BIOMETRICS (2000)
Share Paper
